11
Participants
Start Date
January 31, 2018
Primary Completion Date
December 11, 2023
Study Completion Date
December 11, 2023
Paricalcitol (Zemplar)
combination therapy
HonorHealth Research Institute, Scottsdale
Lead Sponsor
Collaborators (4)
Barts Cancer Institute
OTHER
Abramson Cancer Center at Penn Medicine
OTHER
Salk Institute for Biological Studies
OTHER
Mayo Clinic
OTHER
Princeton University
OTHER
Imaging Endpoints
UNKNOWN
Translational Genomics Research Institute
OTHER
Stand Up To Cancer
OTHER
Cancer Research UK
OTHER
Lustgarten Foundation
OTHER
University of California, San Diego
OTHER
HonorHealth Research Institute
OTHER